Healthtech Startups

Primaya Hospital is a network of 20 private hospitals in Indonesia offering comprehensive healthcare services including specialized centers for maternal/child care, cardiology, trauma, oncology, and other medical specialties, targeting the upper-middle-class segment. The hospital network operates across Java, Sumatra, Kalimantan, and Sulawesi, and is listed on the Indonesian Stock Exchange.

1 investor

Prime Providers offers in-home care, respite, and supportive services for individuals with intellectual and developmental disabilities (I/DD), including personal care, companionship, skill-building, and community integration. It serves individuals and families across California and Oregon using a person-centered approach with trained caregivers.

1 investor

Prime Therapy Partners is a healthcare investor and operator that acquires established physical therapy clinics in growing communities across the United States, integrating them into its network while providing operational support in billing, compliance, technology, and marketing. It owns and partners with regional physical therapy brands including Rocky Mountain Physical Therapy, Boost Physical Therapy & Sports Performance, and Baylife Physical Therapy.

1 investor

Primedea is a platform that connects radiology centers with qualified radiologists to manage capacity shortages and enable remote reporting. The service serves radiology practices and clinics in German-speaking regions, offering flexible radiologist staffing, emergency coverage, and sub-specialization matching.

1 investor

Primo Capital is an Italian independent alternative investments platform that runs venture funds across climate, health, digital, and space sectors. It operates multiple investment strategies and a portfolio of technology companies in Italy.

1 investor

A precision-medicine company that uses radiochemistry and molecular imaging to develop and manufacture radioisotope-based diagnostic and therapeutic drugs, focused on hard-to-treat cancers. It also pursues drug-development partnerships built on its radioisotope platform technology.

1 investor

PrintBio manufactures 3D-printed bioresorbable surgical meshes designed for hernia repair and soft tissue support. The company serves surgeons and hospitals seeking customizable mesh solutions that combine stability and flexibility while reducing infection risk.

1 investor

Prism TPO provides a drug pricing transparency platform for independent oncology practices, integrating distributor pricing, GPO contracts, and reimbursement data to enable clear visibility into net drug economics and informed purchasing decisions.

1 investor

Privia Health operates a network of physician practices organized for value-based care delivery, supporting independent practices and physicians across multiple specialties while maintaining clinical autonomy. The company works to improve patient outcomes and practice economics through its capital-efficient model.

1 investor

PriZm Tx develops treatments for rare genetic disorders, with a focus on MCT8 Deficiency (AHDS), an ultra-rare condition affecting boys. Its lead candidate is a first-in-class therapy for this disorder.

1 investor

Probari provides clinical care management and operational support for nursing homes and long-term care facilities. The company delivers data analytics, clinical oversight, and operational infrastructure to reduce hospitalizations and improve quality measures in post-acute care settings.

1 investor

ProBioGen is a contract development and manufacturing organization (CDMO) that develops and manufactures biopharmaceuticals, viral vectors, and vaccines for biopharma clients. Its services cover cell line development, process development, GMP manufacturing, and analytical services for proteins, antibodies, viral vectors, and vaccines.

1 investor

ProblemShared is an online mental health and neurodevelopmental platform offering remote assessments for ADHD, autism, and specific learning differences, alongside post-diagnostic services including therapy, medication prescribing, and psychoeducation for individuals and institutional partners like NHS trusts and universities in the UK.

1 investor

Procarta Biosystems develops gene control technology to treat drug-resistant bacterial infections, including MRSA. The company was spun out from the John Innes Centre and Plant Biosciences Limited and focuses on anti-infective therapeutics for the biotech and pharmaceutical sector.

1 investor

Procavea Biotech develops a protein-based molecular delivery platform (nonviral protein cages) to address delivery limitations in RNA therapeutics, with applications also in medical imaging. An ETH Zurich spin-off, it targets the pharmaceutical and biotech sector.

1 investor

ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices. It serves the point-of-care diagnostics market.

1 investor

Prodieco designs and manufactures blister tooling and tablet handling solutions for pharmaceutical manufacturers, with in-house validation and testing facilities. Its products are engineered to operate across blister packaging lines used in drug production.

1 investor

ProEves is a platform for early childhood care and education in India that helps parents discover, verify, and book preschools and daycares through physical centres, digital solutions, and at-home support. The platform operates as part of Pluxee, a global employee benefits company, and lists over 12,700 centres across India.

1 investor

Profionics develops host-response biomarker technology for rapid detection and diagnosis of sepsis. The company serves healthcare providers and operates in the diagnostic and biotech sectors.

1 investor

Profit Matters provides bookkeeping and tax services to healthcare practices, helping owners maximize profits and minimize taxes while delivering accounting expertise. The company focuses on setting up financial systems, fixing accounting errors, maintaining monthly records, and providing strategic financial insights to healthcare business owners.

1 investor

ProgenyHealth provides personalized maternity and neonatal intensive care management for health plan members, spanning prenatal care through 12 months postpartum. The company serves payers and physicians with integrated case management, NICU utilization oversight, and claims review services to improve maternal and infant health outcomes while reducing unnecessary healthcare costs.

1 investor

Progressive Dental Marketing provides marketing services, practice development consulting, and staffing support for dental practices seeking to grow their patient base and clinical operations.

1 investor

Progressive NEURO, Inc. develops medical devices for the treatment of ischemic stroke, including products that go beyond traditional aspiration and thrombectomy to improve first-pass efficacy and reduce distal emboli and vessel wall trauma. The company holds seven issued patents covering five different products.

1 investor

Project M is a healthcare platform that uses AI and causal inference to optimize care strategies for individual patients, providing real-time, evidence-based treatment recommendations along with cost and outcome implications. It targets clinical and administrative decision-making to support value-based care, with an initial validated use case in hip fracture treatment and alignment to CMS incentive programs such as TEAM.

1 investor